SAN FRANCISCO — The sumatriptan 3-mg subcutaneous auto-injector (Zembrace SymTouch, Promius Pharma) approved by the US Food and Drug Administration (FDA) for acute treatment of episodic migraine, with ...
Please provide your email address to receive an email when new articles are posted on . A low dose of sumatriptan provided significantly higher 2-hour pain freedom and 2-hour pain relief vs. placebo, ...
Meridian Medical Technologies, Inc., a subsidiary of King Pharmaceuticals, Inc., has been manufacturing auto-injectors for emergency drug delivery for more than 50 years and has provided more than 185 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results